Arsanis, Inc. Purchase Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Securities Purchase Agreement, dated May 15, 2023, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2023
Securities Purchase Agreement, dated June 30, 2022, by and among X4 Pharmaceuticals Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement, dated March 3, 2022, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Purchase Agreement, dated as of January 14, 2022, by and between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC
Purchase Agreements
Arsanis, Inc.
Biotechnology
IL
2022
Securities Purchase Agreement, dated November 5, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2021